Hyperforin-mediated anticancer mechanisms in MDA-MB-231 cell line: insights into apoptotic mediator modulation and caspase activation
Authors:
Open Access
- 8 August 2023
- journal article
- research article
- Published by Taylor & Francis in Journal of Taibah University for Science
- Vol. 17 (1)
Abstract
No abstract availableKeywords
Funding Information
- Fundamental Research (FRGS/1/2019/SKK15/UM/01/2)
- Ministry of Higher Education
- Against Breast Cancer
- University Malaya
- IPPP, UM
This publication has 42 references indexed in Scilit:
- Alterations in tumor necrosis factor signaling pathways are associated with cytotoxicity and resistance to taxanes: a study in isogenic resistant tumor cellsBreast Cancer Research, 2012
- Apoptosis-Inducing Factor: Structure, Function, and Redox RegulationAntioxidants & Redox Signaling, 2011
- Drug Treatment of Cancer Cell Lines: A Way to Select for Cancer Stem Cells?Cancers, 2011
- DNA damage-induced cell death: lessons from the central nervous systemCell Research, 2007
- TNF receptor superfamily‐induced cell death: redox‐dependent executionThe FASEB Journal, 2006
- Mitochondrial-dependent, reactive oxygen species-independent apoptosis by myricetin: roles of protein kinase C, cytochrome c, and caspase cascadeBiochemical Pharmacology, 2005
- Hyperforin Inhibits Cancer Invasion and MetastasisCancer Research, 2004
- Inhibition of tumour cell growth by hyperforin, a novel anticancer drug from St. John's wort that acts by induction of apoptosisOncogene, 2002
- DNA fragmentation in apoptosisCell Research, 2000
- Lactate dehydrogenase (LDH) activity of the number of dead cells in the medium of cultured eukaryotic cells as markerJournal of Biotechnology, 1992